Richmond Pharmacology have developed a resourceful way to use study equipment to help reduce waste produced on site and support clinical facilities in under developed nations. The initiative is the idea of Jennifer Cripps, and her colleagues Kadeem Marshall and Eleanor Wright, who are all Clinical Trials Assistants at Richmond Pharmacology.  

As part of Richmond Pharmacology’s ongoing study activity, we receive excess needles and vacutainers as part of wider supplies onsite to aid taking blood. Richmond Pharmacology already have their own certified supplies of blood collection consumables, meaning needles which are unused have to be discarded. Jennifer and her team thought there would be a better use of the equipment and began investigating a better destination for the excess supplies.

Through her research, a relationship with the Nilda Patricia Hospital in Nicaragua has been established and this month Richmond Pharmacology arranged for over 350 needles and vacutainers to be sent to the hospital which would have otherwise been unused and discarded.

The scheme is increasingly important as Nilda Patricia Hospital suffer from lack of resources, and therefore have come to rely on donations from outside the country in order to upgrade their own resources.

The needles come packaged and are sterile, which the hospital are in high demand of and are particularly useful as they can be used in the wider community, where mobile clinics go out to rural areas to treat patients who cannot easily get to the hospital.

The hospital also has a twinning agreement with George Eliot hospital in Nuneaton. Their arrangement has also helped to provide basic things such as rubber gloves and other basic equipment.

The plan is to maintain this relationship and supply the hospital with supplies that would otherwise go to waste every 3 months and forms part of Richmond Pharmacology’s wider plan to be more resourceful with our intake of study supplies and support clinical facilities worldwide.

Latest news

PATIENT WITH RARE BLEEDING DISORDER BECOMES FIRST TO TEST NEW TREATMENT

May 22, 2024
The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.
Read more

Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations

April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event